{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:44:35Z","timestamp":1791585875775,"version":"4.3.4"},"reference-count":105,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,11]],"date-time":"2027-05-11T00:00:00Z","timestamp":1809993600000},"content-version":"am","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ccell.2026.03.004","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:29:27Z","timestamp":1774538967000},"page":"1080-1096.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Myofibroblast programming blocks differentiation of TLS-organizing fibroblastic reticular cells in pancreatic cancer"],"prefix":"10.1016","volume":"44","author":[{"given":"Elijah","family":"Kirschstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Harder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Krull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Sikorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrijan","family":"Khanal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl F.","family":"Ware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Gough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina H.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6316-4067","authenticated-orcid":false,"given":"Andrew J.","family":"Gunderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2026.03.004_bib1","first-page":"12","article-title":"Cancer Statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ccell.2026.03.004_bib2","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: Advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2026.03.004_bib3","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","article-title":"Challenges and opportunities for pancreatic cancer immunotherapy","volume":"38","author":"Bear","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2026.03.004_bib4","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1001\/jamaoncol.2019.1588","article-title":"Durvalumab with or without tremelimumab for patients with metastatic pancreatic ductal adenocarcinoma: A phase 2 randomized clinical trial","volume":"5","author":"O\u2019Reilly","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ccell.2026.03.004_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s40425-018-0367-1","article-title":"Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): Results from The Cancer Genome Atlas (TCGA)","volume":"6","author":"Danaher","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ccell.2026.03.004_bib6","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2026.03.004_bib7","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1900635","article-title":"Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer","volume":"10","author":"Gunderson","year":"2021","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ccell.2026.03.004_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15095","article-title":"Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer","volume":"8","author":"Carstens","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2026.03.004_bib9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2026.03.004_bib10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","article-title":"B cells are associated to sarcoma survival and immunotherapy response","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2026.03.004_bib11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2026.03.004_bib12","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/s41591-022-01821-3","article-title":"Pembrolizumab in soft tissue sarcomas with tertiary lymphoid structures: A phase 2 PEMBROSARC trial cohort","volume":"28","author":"Italiano","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2026.03.004_bib13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Saut\u00e8s-Fridman","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2026.03.004_bib14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.immuni.2015.08.006","article-title":"Regulatory T cells in tumor associated tertiary lymphoid structures suppress anti-tumor T cell responses","volume":"43","author":"Joshi","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2026.03.004_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.immuni.2021.12.007","article-title":"TGF-\u03b2-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures","volume":"55","author":"Chaurio","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2026.03.004_bib16","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1158\/2326-6066.CIR-17-0131","article-title":"Treg depletion licenses T cell\u2013driven HEV neogenesis and promotes tumor destruction","volume":"5","author":"Colbeck","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ccell.2026.03.004_bib17","doi-asserted-by":"crossref","first-page":"13490","DOI":"10.1073\/pnas.1905301116","article-title":"Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology","volume":"116","author":"Nayar","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2026.03.004_bib18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1074-7613(00)80199-5","article-title":"BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin dependent lymphoid neogenesis","volume":"12","author":"Luther","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2026.03.004_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1074-7613(01)00094-2","article-title":"Targeting of lymphotoxin \u03b1 to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid like tissue","volume":"14","author":"Schrama","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2026.03.004_bib20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.immuni.2005.10.002","article-title":"Lymphotoxin \u03b2 receptor signaling is required for the homeostatic control of HEV differentiation and function","volume":"23","author":"Browning","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2026.03.004_bib21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1084\/jem.20121462","article-title":"Endothelial cell specific lymphotoxin \u03b2 receptor signaling is critical for lymph node and high endothelial venule formation","volume":"210","author":"Onder","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ccell.2026.03.004_bib22","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","article-title":"CCL19 producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis","volume":"42","author":"Zhang","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2026.03.004_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1267654","article-title":"Mechanisms of tertiary lymphoid structure formation: cooperation between inflammation and antigenicity","volume":"14","author":"Khanal","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ccell.2026.03.004_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109422","article-title":"Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer associated fibroblasts","volume":"36","author":"Rodriguez","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2026.03.004_bib25","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1158\/2326-6066.CIR-22-0593","article-title":"T cell\u2013mediated development of stromal fibroblasts with an immune enhancing chemokine profile","volume":"11","author":"Yan","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ccell.2026.03.004_bib26","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1084\/jem.20181216","article-title":"Type I interferon induces CXCL13 to support ectopic germinal center formation","volume":"216","author":"Denton","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ccell.2026.03.004_bib27","doi-asserted-by":"crossref","DOI":"10.1101\/2024.04.30.591846","article-title":"Sustained innate interferon is an essential inducer of tertiary lymphoid structures","volume":"54","author":"Calvanese","year":"2024","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ccell.2026.03.004_bib28","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1158\/2159-8290.CD-19-0644","article-title":"Single cell RNA sequencing reveals stromal evolution into LRRC15+ myofibroblasts as a determinant of patient response to cancer immunotherapy","volume":"10","author":"Dominguez","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2026.03.004_bib29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41586-022-05272-1","article-title":"LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity","volume":"611","author":"Krishnamurty","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2026.03.004_bib30","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","article-title":"IL 1\u2013induced JAK\/STAT signaling is antagonized by TGF \u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2026.03.004_bib31","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross species single cell analysis of pancreatic ductal adenocarcinoma reveals antigen presenting cancer associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2026.03.004_bib32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","article-title":"Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice","volume":"7","author":"Hingorani","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2026.03.004_bib33","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1038\/s41598-023-33508-1","article-title":"Tumor resident memory CD8 T cells and concomitant tumor immunity develop independently of CD4 help","volume":"13","author":"Medler","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ccell.2026.03.004_bib34","doi-asserted-by":"crossref","first-page":"7012","DOI":"10.1038\/s41598-018-25482-w","article-title":"Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity","volume":"8","author":"Crittenden","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ccell.2026.03.004_bib35","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","article-title":"Tumor residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy","volume":"31","author":"Spranger","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2026.03.004_bib36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1126\/science.274.5285.209","article-title":"An \u03b1\u03b2 T cell receptor structure at 2.5 \u00c5 and its orientation in the TCR\u2013MHC complex","volume":"274","author":"Garcia","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ccell.2026.03.004_bib37","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.4049\/jimmunol.159.10.4665","article-title":"Antigen recognition and allogeneic tumor rejection in CD8+ TCR transgenic\/RAG(\u2013\/\u2013) mice","volume":"159","author":"Manning","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.ccell.2026.03.004_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1074-7613(00)80588-9","article-title":"The lymphotoxin receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues","volume":"9","author":"F\u00fctterer","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2026.03.004_bib39","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.ccell.2022.11.002","article-title":"Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed forward loop","volume":"40","author":"Hua","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2026.03.004_bib40","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ccell.2022.01.002","article-title":"Tumor associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD 1 plus CTLA 4 combination immunotherapy","volume":"40","author":"Asrir","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2026.03.004_bib41","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1084\/jem.20021761","article-title":"Ectopic LT\u03b1\u03b2 directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV restricted sulfotransferase","volume":"197","author":"Drayton","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ccell.2026.03.004_bib42","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1084\/jem.183.4.1461","article-title":"Chronic inflammation caused by lymphotoxin is lymphoid neogenesis","volume":"183","author":"Kratz","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ccell.2026.03.004_bib43","doi-asserted-by":"crossref","first-page":"eabg7836","DOI":"10.1126\/sciimmunol.abg7836","article-title":"A reservoir of stem like CD8+ T cells in the tumor draining lymph node preserves the ongoing antitumor immune response","volume":"6","author":"Connolly","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ccell.2026.03.004_bib44","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1+ PD 1+ CD8+ T cells with stem like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2026.03.004_bib45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41586-021-03862-z","article-title":"Functional HPV specific PD 1+ stem like CD8 T cells in head and neck cancer","volume":"597","author":"Eberhardt","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2026.03.004_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms8114","article-title":"Effector lymphocyte induced lymph node like vasculature enables na\u00efve T cell entry into tumours and enhanced anti tumour immunity","volume":"6","author":"Peske","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2026.03.004_bib47","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ccell.2023.04.010","article-title":"Tailoring vascular phenotype through AAV therapy promotes anti tumor immunity in glioma","volume":"41","author":"Ramachandran","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2026.03.004_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175791","article-title":"Pdgfrb is a direct regulatory target of TGF \u03b2 signaling in atrioventricular cushion mesenchymal cells","volume":"12","author":"Peng","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ccell.2026.03.004_bib49","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/2159-8290.CD-19-1353","article-title":"Fibroblast heterogeneity in the pancreatic tumor microenvironment","volume":"10","author":"Helms","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2026.03.004_bib50","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nri3846","article-title":"Lymph node fibroblastic reticular cells in health and disease","volume":"15","author":"Fletcher","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ccell.2026.03.004_bib51","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/mi.2014.14","article-title":"Anti CXCL13 antibody can inhibit the formation of gastric lymphoid follicles induced by Helicobacter infection","volume":"7","author":"Yamamoto","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ccell.2026.03.004_bib52","doi-asserted-by":"crossref","first-page":"14776","DOI":"10.1073\/pnas.1416498111","article-title":"Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts","volume":"111","author":"Ammirante","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2026.03.004_bib53","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1158\/1078-0432.CCR-24-2183","article-title":"Human pancreatic cancer single cell atlas reveals association of CXCL10+ fibroblasts and basal subtype tumor cells","volume":"31","author":"Loveless","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2026.03.004_bib54","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"\u00d6zdemir","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2026.03.004_bib55","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP expressing carcinoma associated fibroblasts synergizes with anti PD L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2026.03.004_bib56","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.1195300","article-title":"Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein alpha","volume":"330","author":"Kraman","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ccell.2026.03.004_bib57","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1158\/2326-6066.CIR-14-0002","article-title":"The carcinoma associated fibroblast expressing fibroblast activation protein and escape from immune surveillance","volume":"2","author":"Fearon","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ccell.2026.03.004_bib58","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1053\/j.gastro.2018.05.051","article-title":"NF \u03baB in pancreatic stellate cells reduces infiltration of tumors by cytotoxic T cells and killing of cancer cells via up regulation of CXCL12","volume":"155","author":"Garg","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ccell.2026.03.004_bib59","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ccell.2021.02.007","article-title":"Type I collagen deletion in \u03b1SMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer","volume":"39","author":"Chen","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2026.03.004_bib60","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2026.03.004_bib61","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/2159-8290.CD-23-0426","article-title":"Senescent CAFs mediate immunosuppression and drive breast cancer progression","volume":"14","author":"Ye","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2026.03.004_bib62","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.1038\/s41467-024-50441-7","article-title":"Senescent cancer associated fibroblasts in pancreatic adenocarcinoma restrict CD8+ T cell activation and limit responsiveness to immunotherapy in mice","volume":"15","author":"Assouline","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2026.03.004_bib63","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1158\/2159-8290.CD-23-0428","article-title":"Senescence defines a distinct subset of myofibroblasts that orchestrates immunosuppression in pancreatic cancer","volume":"14","author":"Belle","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2026.03.004_bib64","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ccell.2022.04.011","article-title":"Mesothelial cell derived antigen presenting cancer associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer","volume":"40","author":"Huang","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2026.03.004_bib65","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ccell.2023.02.015","article-title":"Activated fibroblasts in cancer: perspectives and challenges","volume":"41","author":"Caligiuri","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2026.03.004_bib66","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.cell.2024.10.042","article-title":"Fibroblastic reticular cells generate protective intratumoral T cell environments in lung cancer","volume":"188","author":"Onder","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2026.03.004_bib67","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/s41467-020-15404-8","article-title":"TGF \u03b2 suppresses CD8+ T cell expression of CXCR3 and tumor trafficking","volume":"11","author":"Gunderson","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2026.03.004_bib68","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S1470-2045(22)00446-6","article-title":"Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single arm, phase 2 trial","volume":"23","author":"Yamazaki","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ccell.2026.03.004_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI67428","article-title":"CD4+ follicular helper T cell infiltration predicts breast cancer survival","volume":"123","author":"Gu Trantien","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ccell.2026.03.004_bib70","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1158\/2326-6066.CIR-18-0517","article-title":"A transcriptionally distinct CXCL13+CD103+CD8+ T cell population is associated with B cell recruitment and neoantigen load in human cancer","volume":"7","author":"Workel","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ccell.2026.03.004_bib71","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1038\/s41467-020-19920-5","article-title":"TGF \u03b2 blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon licensed fibroblasts","volume":"11","author":"Grauel","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2026.03.004_bib72","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ccell.2025.12.018","article-title":"Single cell screens identify ADAM12 as a fibroblast checkpoint impeding anti tumor immunity","volume":"44","author":"Li","year":"2026","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2026.03.004_bib73","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1093\/jimmun\/vkaf216","article-title":"TGF-\u03b2 limits proximal CD8+ TCR signaling via PTPN22 following strong and moderate agonism","volume":"214","author":"Gunderson","year":"2025","journal-title":"J. Immunol."},{"key":"10.1016\/j.ccell.2026.03.004_bib74","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.immuni.2012.06.010","article-title":"Lymphotoxin \u03b2 receptor signaling through NF-\u03baB2 RelB pathway reprograms adipocyte precursors as lymph node stromal cells","volume":"37","author":"B\u00e9n\u00e9zech","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2026.03.004_bib75","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.immuni.2018.03.025","article-title":"T cell receptor regulated TGF \u03b2 type I receptor expression determines T cell quiescence and activation","volume":"48","author":"Tu","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2026.03.004_bib76","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/eji.201242471","article-title":"Lymphotoxin \u03b11\u03b22 expression on B cells is required for follicular dendritic cell activation during the germinal center response","volume":"43","author":"Myers","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ccell.2026.03.004_bib77","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","article-title":"TGF-\u03b2 directly targets cytotoxic T cell functions during tumor evasion of immune surveillance","volume":"8","author":"Thomas","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2026.03.004_bib78","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ni.3836","article-title":"De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors","volume":"18","author":"Johansson Percival","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2026.03.004_bib79","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211574","article-title":"TGF\u03b2 regulates the stem like state of PD 1+ TCF 1+ virus specific CD8 T cells during chronic infection","volume":"219","author":"Hu","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ccell.2026.03.004_bib80","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1158\/0008-5472.CAN-23-2716","article-title":"LT\u03b2R agonism promotes antitumor immune responses via modulation of the tumor microenvironment","volume":"84","author":"An","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2026.03.004_bib81","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/s41590-025-02259-8","article-title":"Simultaneous STING and lymphotoxin \u03b2 receptor activation induces B cell responses in tertiary lymphoid structures to potentiate antitumor immunity","volume":"26","author":"Sawada","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2026.03.004_bib82","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/s41586-024-08426-5","article-title":"IL-33 activated ILC2s induce tertiary lymphoid structures in pancreatic cancer","volume":"638","author":"Amisaki","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2026.03.004_bib83","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.4049\/jimmunol.159.7.3288","article-title":"Characterization of lymphotoxin \u03b1\u03b2 complexes on the surface of mouse lymphocytes","volume":"159","author":"Browning","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.ccell.2026.03.004_bib84","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1073\/pnas.96.11.6336","article-title":"Requirement for membrane lymphotoxin in natural killer cell development","volume":"96","author":"Iizuka","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2026.03.004_bib85","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.4049\/jimmunol.163.10.5358","article-title":"Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells","volume":"163","author":"Kashii","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.ccell.2026.03.004_bib86","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","article-title":"Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression","volume":"2","author":"Vanhersecke","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ccell.2026.03.004_bib87","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1038\/s41467-018-06654-8","article-title":"TGF-\u03b2-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure","volume":"9","author":"Chakravarthy","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2026.03.004_bib88","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1158\/0008-5472.CAN-21-4141","article-title":"Cancer-associated fibroblasts suppress CD8+ T-cell infiltration and confer resistance to immune-checkpoint blockade","volume":"82","author":"Jenkins","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2026.03.004_bib89","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/s41588-024-01899-0","article-title":"Five latent factors underlie response to immunotherapy","volume":"56","author":"Usset","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2026.03.004_bib90","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1158\/2159-8290.CD-19-1384","article-title":"Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer","volume":"10","author":"Kieffer","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2026.03.004_bib91","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1158\/0008-5472.CAN-12-4601","article-title":"Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner","volume":"73","author":"Mace","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2026.03.004_bib92","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1038\/s41467-023-39762-1","article-title":"Cancer-associated fibroblast classification in single-cell and spatial proteomics data","volume":"14","author":"Cords","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2026.03.004_bib93","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.ccell.2025.03.004","article-title":"Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics","volume":"43","author":"Liu","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2026.03.004_bib94","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1158\/2159-8290.CD-21-1714","article-title":"Spatial positioning and matrix programs of cancer-associated fibroblasts promote T-cell exclusion in human lung tumors","volume":"12","author":"Grout","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2026.03.004_bib95","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.ccell.2024.08.020","article-title":"Cross-tissue human fibroblast atlas reveals myofibroblast subtypes with distinct roles in immune modulation","volume":"42","author":"Gao","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2026.03.004_bib96","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41416-018-0246-z","article-title":"Galunisertib plus gemcitabine vs gemcitabine for first-line treatment of patients with unresectable pancreatic cancer","volume":"119","author":"Melisi","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccell.2026.03.004_bib97","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1158\/1078-0432.CCR-21-1504","article-title":"First-in-human phase I study of a next-generation, oral, TGF\u03b2 receptor 1 inhibitor, LY3200882, in patients with advanced cancer","volume":"27","author":"Yap","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2026.03.004_bib98","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/jamaoncol.2019.0892","article-title":"Total neoadjuvant therapy with FOLFIRINOX in combination with losartan followed by chemoradiotherapy for locally advanced pancreatic cancer: a phase 2 clinical trial","volume":"5","author":"Murphy","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ccell.2026.03.004_bib99","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1016\/j.cell.2021.11.007","article-title":"Neoantigen driven B cell and CD4+ T follicular helper cell collaboration promotes robust anti-tumor CD8+ T cell responses","volume":"184","author":"Cui","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2026.03.004_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccell.2025.12.011","article-title":"B cells disrupt tertiary lymphoid structure formation and suppress anti-tumor immunity","volume":"44","author":"Chen","year":"2026","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2026.03.004_bib101","doi-asserted-by":"crossref","first-page":"e0238380","DOI":"10.1371\/journal.pone.0238380","article-title":"Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancer","volume":"15","author":"Bernard","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ccell.2026.03.004_bib102","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","article-title":"SCANPY: large-scale single-cell gene expression data analysis","volume":"19","author":"Wolf","year":"2018","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2026.03.004_bib103","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/s41587-023-01657-3","article-title":"TACCO unifies annotation transfer and decomposition of cell identities for single-cell and spatial omics","volume":"41","author":"Mages","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2026.03.004_bib104","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2026.03.004_bib105","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153561082600156X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153561082600156X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:26:15Z","timestamp":1778617575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153561082600156X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":105,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S153561082600156X"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2026.03.004","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myofibroblast programming blocks differentiation of TLS-organizing fibroblastic reticular cells in pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2026.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}